Literature DB >> 26345687

Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation.

Dror Meirow1, Hadassa Roness2, Stine Gry Kristensen3, Claus Yding Andersen3.   

Abstract

Ovarian tissue cryopreservation and transplantation (OTCP) is gaining increasing traction in the field of fertility preservation as a result of accumulated successes. We now have a decade of experience with the technique, with tens of live births and greater than 90% return of ovarian function in graft recipients. Recently, a novel method of OTCP has been described, termed in vitro activated OTCP which proposes significant changes to the standard protocol. This method aims to stimulate activation of dormant follicles within the grafts prior to transplantation and ensure that mature oocytes can be generated in the immediate short term after transplantation. By contrast, conventional OTCP seeks to maintain dormancy and thus preserve the follicle reserve in the graft with the aim of maximizing graft lifespan. This opinion paper will compare the two methods of OTCP, highlighting their respective advantages and disadvantages, and provide suggestions as to when to apply either one of these methods in a clinical setting.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Keywords:  fertility preservation; follicle activation; ovarian tissue cryopreservation; ovarian tissue transplantation

Mesh:

Year:  2015        PMID: 26345687     DOI: 10.1093/humrep/dev210

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

1.  Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) pre-exposure ensures follicle integrity during in vitro culture of ovarian tissue but not during cryopreservation in the domestic cat model.

Authors:  Nae Tanpradit; Kaywalee Chatdarong; Pierre Comizzoli
Journal:  J Assist Reprod Genet       Date:  2016-09-17       Impact factor: 3.412

2.  Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation.

Authors:  Zohar Gavish; Itay Spector; Gil Peer; Stefan Schlatt; Joachim Wistuba; Hadassa Roness; Dror Meirow
Journal:  J Assist Reprod Genet       Date:  2017-11-03       Impact factor: 3.412

Review 3.  Fertility preservation through gonadal cryopreservation.

Authors:  Lalitha Devi; Sandeep Goel
Journal:  Reprod Med Biol       Date:  2016-03-11

Review 4.  Oncofertility-An emerging discipline rather than a special consideration.

Authors:  Antoinette Anazodo; Lauren Ataman-Millhouse; Yasmin Jayasinghe; Teresa K Woodruff
Journal:  Pediatr Blood Cancer       Date:  2018-07-03       Impact factor: 3.167

Review 5.  Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.

Authors:  Vitaly A Kushnir; David B Seifer; David H Barad; Aritro Sen; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2017-06-22       Impact factor: 3.412

6.  Long-term storage does not impact the quality of cryopreserved human ovarian tissue.

Authors:  Raffaella Fabbri; Maria Macciocca; Rossella Vicenti; Gianandrea Pasquinelli; Giacomo Caprara; Sabrina Valente; Renato Seracchioli; Roberto Paradisi
Journal:  J Ovarian Res       Date:  2016-08-24       Impact factor: 4.234

7.  Cell-free therapy with the secretome of adipose tissue-derived stem cells in rats' frozen-thawed ovarian grafts.

Authors:  Luciana Lamarão Damous; Ana Elisa Teófilo Saturi de Carvalho; Juliana Sanajotti Nakamuta; Marcos Eiji Shiroma; Andressa Cristina Sposato Louzada; José Maria Soares-Jr; José Eduardo Krieger; Edmund C Baracat
Journal:  Stem Cell Res Ther       Date:  2018-11-21       Impact factor: 6.832

Review 8.  FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences?

Authors:  Michael von Wolff; Claus Yding Andersen; Teresa K Woodruff; Frank Nawroth
Journal:  Clin Med Insights Reprod Health       Date:  2019-04-30

Review 9.  Potential roles of experimental reproductive technologies in infertile women with diminished ovarian reserve.

Authors:  Zexu Jiao; Orhan Bukulmez
Journal:  J Assist Reprod Genet       Date:  2021-06-07       Impact factor: 3.357

10.  Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women.

Authors:  Ralf Dittrich; Sabine Kliesch; Andreas Schüring; Magdalena Balcerek; Dunja M Baston-Büst; Ramona Beck; Matthias W Beckmann; Karolin Behringer; Anja Borgmann-Staudt; Wolfgang Cremer; Christian Denzer; Thorsten Diemer; Almut Dorn; Tanja Fehm; Rüdiger Gaase; Ariane Germeyer; Kristina Geue; Pirus Ghadjar; Maren Goeckenjan; Martin Götte; Dagmar Guth; Berthold P Hauffa; Ute Hehr; Franc Hetzer; Jens Hirchenhain; Wilfried Hoffmann; Beate Hornemann; Andreas Jantke; Heribert Kentenich; Ludwig Kiesel; Frank-Michael Köhn; Matthias Korell; Sigurd Lax; Jana Liebenthron; Michael Lux; Julia Meißner; Oliver Micke; Najib Nassar; Frank Nawroth; Verena Nordhoff; Falk Ochsendorf; Patricia G Oppelt; Jörg Pelz; Beate Rau; Nicole Reisch; Dorothea Riesenbeck; Stefan Schlatt; Annekathrin Sender; Roxana Schwab; Friederike Siedentopf; Petra Thorn; Steffen Wagner; Ludwig Wildt; Pauline Wimberger; Tewes Wischmann; Michael von Wolff; Laura Lotz
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-06-25       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.